Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02702609 · ClinicalTrials.gov registry record · NA
Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System
A NA study of Dental Implants and Alveolar Ridge Preservation, sponsored by Sunstar Americas.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT02702609: Completed NA study of Dental Implants and Alveolar Ridge Preservation, sponsored by Sunstar Americas.
NCT02702609 is a NA study of Dental Implants and Alveolar Ridge Preservation that has completed, run by Sunstar Americas. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02702609, a NA study of Dental Implants and Alveolar Ridge Preservation, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
Randomized Controlled study to compare the effectiveness of two different treatment approaches using a new moldable beta-tricalcium phosphate(TCP) bone graft material in ridge preservation of an atraumatic extraction socket site compared to allograft with collagen plug.
Primary Outcome
Cone-beam computed tomography (CBCT) is taken at the ridge preservation procedure (baseline) and 4 months after the procedure. Linear measurement of horizontal ridge width is measured at 1 mm apical to the crest. Change of horizontal ridge width = (Baseline measurement - 4 months measurement)
Conditions Studied
Interventions
- DEVICE easy-graft CLASSIC
- DEVICE FDBA with collagen plug
Study Locations (2)
Iowa
- The University of Iowa College of Dentistry - Iowa City
Maryland
- University of Maryland School of Dentistry - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-08-02 |
| Est. Completion | 2019-08-19 |
| Phase | NA |
What the finished NCT02702609 record still lists
NCT02702609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Dental Implants appearing as the primary indexed condition, and to 2 interventions - of which easy-graft CLASSIC is the first listed.
NCT02702609 reports a single indexed study location in Iowa, Maryland.
Frequently Asked Questions
What is clinical trial NCT02702609 about?
NCT02702609 is a clinical study titled "Assessment of Ridge Preservation Using Moldable Beta-tricalcium Phosphate Bone Grafting System". Randomized Controlled study to compare the effectiveness of two different treatment approaches using a new moldable beta-tricalcium phosphate(TCP) bone graft material in ridge preservation of an atraumatic extraction socket site compared to allograft with collagen plug.
What is the current status of trial NCT02702609?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-08-02. Estimated completion is 2019-08-19.
What conditions does trial NCT02702609 study?
This clinical trial studies the following conditions: Dental Implants, Alveolar Ridge Preservation.
What interventions are being tested in trial NCT02702609?
The interventions under investigation include: easy-graft CLASSIC (DEVICE), FDBA with collagen plug (DEVICE).
Who is sponsoring clinical trial NCT02702609?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02702609 being conducted?
This trial has 2 study locations across Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Implants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02702609's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI